<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02065804</url>
  </required_header>
  <id_info>
    <org_study_id>H-3-2011-130-lap</org_study_id>
    <nct_id>NCT02065804</nct_id>
  </id_info>
  <brief_title>Trigger-point Blockade in Persistent Pain After Laparoscopical Groin Hernia Repair</brief_title>
  <acronym>Trigger-lap</acronym>
  <official_title>Trigger-point Blockade in Persistent Pain After Laparoscopically Assisted Groin Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Groin hernia repair is a common procedure performed in approximately 2,000 patients per one
      million inhabitants. Severe chronic pain following groin hernia repair is seen in 2-5% of the
      patients indicating that a large number of patients each year suffer from debilitating
      reduction in health-related quality of life.

      This study examines the effect of ultra-sound guided blocks with local anesthesia in the
      groin in regard to pain relief and sleep quality.

      The hypothesis of the study is that a block will confer significant pain relief to patients
      with severe chronic pain following laparoscopical groin hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This placebo-controlled, randomized, double-blind, cross-over study in subjects with severe
      pain after laparoscopically assisted groin hernia repair, examines the effect of an
      ultra-sound guided local anesthetic block of a trigger-point, situated near the spermatic
      cord at the superficial inguinal ring.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Normalized summed pain intensity differences (SPID)</measure>
    <time_frame>20 min</time_frame>
    <description>The number of patients with normalized summed pain intensity differences (SPID) of more or equal to 50% after bupivacaine AND SPID less or equal to 25% after placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thermal thresholds</measure>
    <time_frame>20 min</time_frame>
    <description>Quantitative changes in thermal thresholds (warmth detection threshold, cool detection thresholds, heat pain threshold) after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Suprathreshold heat stimulation</measure>
    <time_frame>20 min</time_frame>
    <description>Quantitative changes in pain rating to suprathreshold heat stimulation after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure pain thresholds</measure>
    <time_frame>20 min</time_frame>
    <description>Quantitative changes in pain rating to pressure algometry stimulation after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory mapping</measure>
    <time_frame>20 min</time_frame>
    <description>Quantitative changes in area of cool hypoesthesia assessed by a thermal roller after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain questionnaire</measure>
    <time_frame>7 days</time_frame>
    <description>Quantitative changes in summed pain intensity differences (SPIDs) assessed morning and evening after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality questionnaire</measure>
    <time_frame>7 days</time_frame>
    <description>Quantitative changes in sleep quality assessed each morning after bupivacaine compared to placebo</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Active drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 ml of bupivacaine 2.5 mg/ml deposited by ultra-sound guidance around the spermatic cord</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 ml of normal saline deposited by ultra-sound guidance around the spermatic cord</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>injection, once, 5 min</description>
    <arm_group_label>Active drug</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Bupivacain &quot;SAD&quot;</other_name>
    <other_name>0.9% Sodium-chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with persistent pain (&lt; 6 mo) after laparoscopical groin hernia repair

          -  Patients with maximal pain area 3 cm or less from the superficial inguinal ring

          -  Patients living in the Capital Region of Denmark (Region Hovedstaden) or the Region of
             Zealand (Region Sj√¶lland)

        Exclusion Criteria:

          -  Known allergy to bupivacaine or other local anesthetics of amide-type

          -  Declared incapable of making his/hers own affairs

          -  Does not comprehend Danish in writing or speech

          -  Cognitive impairment to a degree influencing the testing reliability

          -  Known recurrence of the inguinal hernia

          -  Other surgical procedures performed in the groin or on the external genitals

          -  Neuropathy affecting the groin region caused by other conditions, e.g. post-stroke,
             multiple sclerosis, herniated intervertebral disc

          -  Abuse of alcohol or drugs

          -  Unable to cooperate with the sensory examinations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mads Werner</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multidisciplinary Pain Center, Neuroscience Center, Rigshospitalet, Copenhagen University Hospital, DENMARK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Kehlet, MD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>Section of Surgical Pathophysiology, Juliane Marie Center, Copenhagen University Hospital, DENMARK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Multidisciplinary Pain Center, Neuroscience Center, Copenhagen University Hospital, DENMARK</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.sages.org/publications/patient-information/patient-information-for-laparoscopic-inguinal-hernia-repair-from-sages/</url>
    <description>Patient Information for Laparoscopic Inguinal Hernia Repair from SAGES (Society of American Gastrointestinal and Endoscopic Surgeons)</description>
  </link>
  <reference>
    <citation>Linderoth G, Kehlet H, Aasvang EK, Werner MU. Neurophysiological characterization of persistent pain after laparoscopic inguinal hernia repair. Hernia. 2011 Oct;15(5):521-9. doi: 10.1007/s10029-011-0815-z. Epub 2011 Apr 9.</citation>
    <PMID>21479588</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2014</study_first_submitted>
  <study_first_submitted_qc>February 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2014</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>mads u werner</investigator_full_name>
    <investigator_title>MD, DMSc</investigator_title>
  </responsible_party>
  <keyword>Herniorrhaphy</keyword>
  <keyword>Surgical Equipment</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Inguinal Herniorrhaphy</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Surgical Outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be submitted as supplementary material in the final manuscript</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

